Navigating 4 Analyst Ratings For Pediatrix Medical Group
In the preceding three months, 4 analysts have released ratings for Pediatrix Medical Group (NYSE:MD), presenting a wide…
Earnings Scheduled For February 20, 2024
Companies Reporting Before The Bell
• Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.36 per share on revenue of $7.38 billion.
Recap: Pediatrix Medical Group Q4 Earnings
Pediatrix Medical Group (NYSE:MD) reported its Q4 earnings results on Tuesday, February 20, 2024 at 06:00 AM. Here’s…
Earnings Preview For Pediatrix Medical Group
Pediatrix Medical Group (NYSE:MD) is set to give its latest quarterly earnings report on Tuesday, 2024-02-20. Here’s what…
Top 5 Health Care Stocks That Could Blast Off In December
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Why Children’s Place Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Shares of The Children's Place, Inc. (NASDAQ: PLCE) moved lower during Thursday’s session following weak quarterly earnings.
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
OmniLit Acquisition Corp. (NASDAQ: OLIT) jumped 53.2% to $15.53. OmniLit announced that its merger with Syntec was approved by shareholders.
Earnings Scheduled For November 2, 2023
Companies Reporting Before The Bell
• AudioCodes (NASDAQ:AUDC) is estimated to report quarterly earnings at $0.18 per share on revenue of $61.52 million.
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell
• Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Concerned Shareholders Of Cano Health Nominate Highly Qualified, Independent Director Candidates And Propose Removal Of Dr. Marlow Hernandez From Board For Cause
Group Details the Case for Urgent Change at Cano Following an Extended Period of Underperformance, Failed Capital Allocation, and Extremely Poor Governance and Strategic Execution
Urges Stockholders